HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.


More in this Section

Farmers call for better share of retail prices from 'modern-day dictators'

Revenue officers seize 26,000 litres of beer at Rosslare

Man arrested following cannabis seizures in Dublin and Kildare

Barry McElduff’s resignation takes effect under arcane procedure


Today's Stories

Kerry Babies: 34 years on, an apology for Joanne

Government plans local property tax overhaul

Most in Dublin can’t buy a one-bed home

Girls: Easier ways to gain points than higher-level maths

Lifestyle

Hopefully she had an idea...

Power of the press: Meryl Streep and Tom Hanks discuss 'The Post'

What to expect from Call The Midwife

More From The Irish Examiner